{"article":{"annotation":{"article_id":"who-global-respiratory-virus-surveillance-week44-2026-11-01","available_at":"2026-11-12T01:20:44.184183Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"28bd47e509a5d7b6e24fa069f464cf4269aef1c3aa8fbcdbe523dc49fc844e9c","input_sha256":"3f5af6563a1e3f7a2d829c64cec5c3b9814e9e3f084dc95e67caf40b7fd63453","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000448","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: influenza","source_urls":["https://www.who.int/publications/m/item/global-respiratory-virus-activity--weekly-update-n--603","https://cdn.who.int/media/docs/default-source/influenza/influenza-updates/2026/202644_rvupdate_603.pdf?download=true&sfvrsn=13cadbf3_3"]}],"method":"controlled-rules-v1","rule_id":"communicable-disease","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=en","category":"health","content":{"key_points":[],"paragraphs":["A World Health Organization weekly surveillance update published on 11 November found that influenza positivity remained below 10 percent globally in week 44, which ended on 1 November. The headline conceals sharply different patterns between broad regions. Positivity continued to rise in northern temperate and subtropical areas, remained below 5 percent in southern temperate and subtropical areas, and was above 10 percent in tropical areas.","These figures describe the share of tested specimens that were positive within surveillance systems. They are not estimates of the share of people infected, nor a count of all infections in the population. WHO says the report combines sentinel surveillance with other systematic virologic monitoring, and that countries use different methods and testing practices. The denominator is therefore the specimens reported for testing, not the total population.","Influenza detections remained low in WHO's global summary, with influenza A predominant. Yet the map of elevated positivity was mixed. In the northern hemisphere, some countries in Central America and the Caribbean, Northern Europe, and Southern and Eastern Asia exceeded 10 percent positivity. WHO reported rates above 30 percent in some countries in Central America and the Caribbean and parts of Western, Southern and South Eastern Asia, as well as individual countries in Western and Eastern Africa.","The southern hemisphere also contained local increases despite its lower broad regional summary. Positivity was above 10 percent in some countries in Tropical South America and Oceania, and in individual countries in Temperate South America and Eastern Africa. One country in South Eastern Asia exceeded 30 percent. WHO reported increasing activity in one country in Tropical South America. A broad hemispheric average can therefore move in a different direction from a local national signal.","The circulating influenza types also varied by transmission zone. In zones with elevated positivity, A(H1N1)pdm09 was predominant in Northern Europe, Eastern Africa, Western and South Eastern Asia, and Oceania. In Eastern Asia, A(H1N1)pdm09 and A(H3N2) were co-dominant. Influenza A and B were co-dominant in Central America and the Caribbean, Temperate South America, and Southern Asia. Influenza B was predominant in Tropical South America, Western Africa, and Middle Africa.","The update described SARS-CoV-2 positivity as stable and low across most reporting countries, while recording pockets above 10 percent in parts of South Western Europe and single countries in Central America and the Caribbean, Northern Europe, and Western Asia. One country in Northern Africa was above 30 percent. WHO also noted small increases in several named areas. These are surveillance signals for the reporting week, not evidence that every country or community followed the same trend.","RSV positivity remained low globally in the report, but local readings exceeded 10 percent in a few countries in Central America and the Caribbean and in single countries in Tropical South America, Southern Asia, and Eastern Asia. Rates over 30 percent were reported in individual countries in Temperate South America and Southern Asia. Some areas reported elevated influenza and RSV at the same time, while the source cautions that different viruses may be sampled from different surveillance sources.","WHO's severity section is a separate kind of national report. In northern temperate and subtropical areas, influenza-specific transmissibility was below the local seasonal threshold in 10 countries and classified as low in six; assessments based on syndromic data were below threshold in seven and low in one. The report says these assessments use each country's historical context and methods. They should not be ranked as though one country used an identical scale to another.","The report's methods explain why the maps smooth short-term movements. For influenza and SARS-CoV-2 trend analysis, WHO averaged positivity over three weeks and included countries that tested at least 10 specimens in at least two of those three weeks. Influenza subtype maps aggregate three weeks backward until a transmission zone reaches at least 100 tested samples. Those thresholds apply to specified analytical products, not to all figures in the bulletin.","WHO says reporting completeness can change, countries can revise prior data, and grouped regions do not imply uniform transmission inside them. The summary was based on RespiMart data last updated on 9 November at 00:30 UTC, two days before publication. Newsverum reviewed the bulletin and its methods. The update supports a picture of uneven activity and changing test positivity, not a diagnosis, a forecast, or a direct comparison of infection risk between populations."],"sections":[]},"corrections":[],"country":null,"data":{"blocks":[{"description":{"ar":"انتهى الأسبوع 44 في 1 نوفمبر 2026 ونشرت النشرة في 11 نوفمبر.","de":"Woche 44 endete am 1. November 2026; der Bericht erschien am 11. November.","en":"Week 44 ended on 1 November 2026; the bulletin was published on 11 November.","es":"La semana 44 terminó el 1 de noviembre de 2026; el boletín se publicó el 11 de noviembre.","fr":"La semaine 44 s’est terminée le 1er novembre 2026; le bulletin a paru le 11 novembre.","pt":"A semana 44 terminou em 1º de novembro de 2026; o boletim foi publicado em 11 de novembro.","tr":"44. hafta 1 Kasım 2026’da sona erdi; bülten 11 Kasım’da yayımlandı."},"id":"who-respiratory-week44","items":[{"date":"2026-11-01","description":{"ar":"انتهى الأسبوع 44 في 1 نوفمبر 2026 ونشرت النشرة في 11 نوفمبر.","de":"Woche 44 endete am 1. November 2026; der Bericht erschien am 11. November.","en":"Week 44 ended on 1 November 2026; the bulletin was published on 11 November.","es":"La semana 44 terminó el 1 de noviembre de 2026; el boletín se publicó el 11 de noviembre.","fr":"La semaine 44 s’est terminée le 1er novembre 2026; le bulletin a paru le 11 novembre.","pt":"A semana 44 terminou em 1º de novembro de 2026; o boletim foi publicado em 11 de novembro.","tr":"44. hafta 1 Kasım 2026’da sona erdi; bülten 11 Kasım’da yayımlandı."},"label":{"ar":"نهاية الأسبوع الذي يغطيه تحديث الترصد لمنظمة الصحة العالمية","de":"Ende der vom WHO Überwachungsbericht erfassten Woche","en":"End of the week covered by the WHO surveillance update","es":"Fin de la semana cubierta por el informe de vigilancia de la OMS","fr":"Fin de la semaine couverte par le bulletin de surveillance de l’OMS","pt":"Fim da semana coberta pela atualização de vigilância da OMS","tr":"WHO gözetim raporunun kapsadığı haftanın sonu"},"status":"occurred"}],"methodology":{"ar":"يفصل المصدر بين نهاية الأسبوع وتاريخ نشر التقرير.","de":"Die Quelle unterscheidet das Ende der Woche vom Erscheinungsdatum.","en":"The source distinguishes the week end from report publication date.","es":"La fuente distingue el fin de semana y la fecha de publicación.","fr":"La source distingue la fin de semaine et la date de publication.","pt":"A fonte distingue o fim da semana da data de publicação.","tr":"Kaynakta hafta bitiş günü ve rapor yayımlanma tarihi ayrı verilmiştir."},"sourceUrls":["https://www.who.int/publications/m/item/global-respiratory-virus-activity--weekly-update-n--603","https://cdn.who.int/media/docs/default-source/influenza/influenza-updates/2026/202644_rvupdate_603.pdf?download=true&sfvrsn=13cadbf3_3"],"title":{"ar":"فترة الترصد الأسبوعي للمنظمة","de":"WHO Wochenzeitraum der Überwachung","en":"WHO weekly surveillance period","es":"Período de vigilancia semanal de la OMS","fr":"Période de surveillance hebdomadaire OMS","pt":"Período de vigilância semanal da OMS","tr":"WHO haftalık gözetim dönemi"},"type":"events","updatedAt":"2026-11-12T01:09:27+00:00"},{"description":{"ar":"أفادت المنظمة بأن إيجابية الإنفلونزا عالميا دون 10 في المئة في الأسبوع 44. والمقياس حصة العينات المفحوصة.","de":"Die WHO meldete für Woche 44 eine weltweite Influenza Positivität unter 10 %. Gemessen wird der Anteil getesteter Proben.","en":"WHO reported global influenza positivity below 10% for week 44. The measure is a share of tested specimens.","es":"La OMS informó de una positividad mundial de gripe inferior al 10 % en la semana 44. La medida corresponde a muestras analizadas.","fr":"L’OMS a rapporté une positivité grippale mondiale inférieure à 10 % en semaine 44. La mesure porte sur les échantillons testés.","pt":"A OMS informou positividade global de influenza abaixo de 10 % na semana 44. A medida é a parcela das amostras testadas.","tr":"WHO, 44. haftada küresel influenza pozitifliğini yüzde 10’un altında bildirdi. Ölçüm test edilen örneklerin payıdır."},"id":"who-global-influenza-specimen-positivity","items":[{"basis":"observed","label":{"ar":"الحد الأعلى لإيجابية عينات الإنفلونزا عالميا","de":"Obergrenze der weltweiten Positivität von Influenzaproben","en":"Upper bound of influenza specimen positivity globally","es":"Límite superior de positividad mundial de muestras de influenza","fr":"Borne supérieure de positivité des échantillons grippaux dans le monde","pt":"Limite superior da positividade global de amostras de influenza","tr":"Küresel influenza örneklerinde pozitiflik üst sınırı"},"measure":{"aggregation":"rate","frequency":"weekly","geography":"world","id":"who-global-influenza-test-positivity","periodRole":"reference-period","unitCode":"percent"},"period":"2026-11-01","periodStart":"2026-10-26","unit":"percent","value":10,"valueQualifier":"upper-bound"}],"methodology":{"ar":"عينات فيروسية أبلغت عنها البلدان المشاركة في فلو نت ونظام GISRS. يمثل الحد الأعلى 10 في المئة إفادة المنظمة بأن النسبة دون 10. والمقام عينات مفحوصة لا أشخاصا.","de":"Virologische Proben der an FluNet und GISRS beteiligten Länder. Die obere Grenze von 10 % bildet die WHO Angabe unter 10 % ab. Der Nenner sind getestete Proben, nicht Menschen.","en":"Virologic specimens reported by countries contributing to WHO FluNet and GISRS. The 10% upper bound represents WHO’s finding of below 10%. The denominator is tested specimens, not people.","es":"Muestras virológicas comunicadas por países que participan en FluNet y GISRS. El límite superior del 10 % refleja el hallazgo inferior al 10 % de la OMS. El denominador son muestras analizadas, no personas.","fr":"Échantillons virologiques déclarés par les pays participant à FluNet et au GISRS. La borne de 10 % reflète le constat de l’OMS inférieur à 10 %. Le dénominateur est constitué des échantillons testés, non des personnes.","pt":"Amostras virológicas notificadas por países participantes do FluNet e GISRS. O limite superior de 10 % representa o resultado da OMS abaixo de 10 %. O denominador são amostras testadas, não pessoas.","tr":"WHO FluNet ve GISRS’ye katılan ülkelerin raporladığı virolojik örnekler. Küresel yüzde 10 üst sınırı WHO’nun yüzde 10’un altı bulgusunu gösterir. Payda incelenen örneklerdir, nüfus değildir."},"sourceUrls":["https://cdn.who.int/media/docs/default-source/influenza/influenza-updates/2026/202644_rvupdate_603.pdf?download=true&sfvrsn=13cadbf3_3"],"title":{"ar":"إيجابية فحوص الإنفلونزا عالميا","de":"Weltweite Influenza Testpositivität","en":"Global influenza test positivity","es":"Positividad mundial de pruebas de influenza","fr":"Positivité mondiale des tests grippaux","pt":"Positividade global dos testes de influenza","tr":"Küresel influenza test pozitifliği"},"type":"metrics","updatedAt":"2026-11-12T01:09:27+00:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01/data/who-respiratory-week44?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01/data/who-respiratory-week44?lang=en&format=json"},"id":"who-respiratory-week44"},{"formats":{"csv":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01/data/who-global-influenza-specimen-positivity?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01/data/who-global-influenza-specimen-positivity?lang=en&format=json"},"id":"who-global-influenza-specimen-positivity"}],"data_types":["events","metrics"],"editorial_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-032261d1-ccde-542d-ad8c-3df4b964546f","event_period":"2026-11-01","event_period_basis":"event-or-reference-period","id":"who-global-respiratory-virus-surveillance-week44-2026-11-01","image":null,"importance":0.6,"language":"en","modified_at":"2026-11-12T01:20:43+00:00","publication_basis":"publication-record","published_at":"2026-11-12T01:20:43+00:00","reading_minutes":4,"region":"world","relations":[],"section_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"who-global-respiratory-virus-surveillance-week44-2026-11-01","sources":[{"checkedAt":"2026-11-12","name":"WHO Global Respiratory Virus Activity weekly update 603, week 44","publishedAt":"2026-11-11","url":"https://www.who.int/publications/m/item/global-respiratory-virus-activity--weekly-update-n--603"},{"checkedAt":"2026-11-12","name":"WHO Global Respiratory Virus Activity weekly update 603, five page report","publishedAt":"2026-11-11","url":"https://cdn.who.int/media/docs/default-source/influenza/influenza-updates/2026/202644_rvupdate_603.pdf?download=true&sfvrsn=13cadbf3_3"}],"summary":"Global influenza test positivity was below 10% in the week ending 1 November. Sample rates are not population infection rates.","text":"Global influenza test positivity was below 10% in the week ending 1 November. Sample rates are not population infection rates.\n\nA World Health Organization weekly surveillance update published on 11 November found that influenza positivity remained below 10 percent globally in week 44, which ended on 1 November. The headline conceals sharply different patterns between broad regions. Positivity continued to rise in northern temperate and subtropical areas, remained below 5 percent in southern temperate and subtropical areas, and was above 10 percent in tropical areas.\n\nThese figures describe the share of tested specimens that were positive within surveillance systems. They are not estimates of the share of people infected, nor a count of all infections in the population. WHO says the report combines sentinel surveillance with other systematic virologic monitoring, and that countries use different methods and testing practices. The denominator is therefore the specimens reported for testing, not the total population.\n\nInfluenza detections remained low in WHO's global summary, with influenza A predominant. Yet the map of elevated positivity was mixed. In the northern hemisphere, some countries in Central America and the Caribbean, Northern Europe, and Southern and Eastern Asia exceeded 10 percent positivity. WHO reported rates above 30 percent in some countries in Central America and the Caribbean and parts of Western, Southern and South Eastern Asia, as well as individual countries in Western and Eastern Africa.\n\nThe southern hemisphere also contained local increases despite its lower broad regional summary. Positivity was above 10 percent in some countries in Tropical South America and Oceania, and in individual countries in Temperate South America and Eastern Africa. One country in South Eastern Asia exceeded 30 percent. WHO reported increasing activity in one country in Tropical South America. A broad hemispheric average can therefore move in a different direction from a local national signal.\n\nThe circulating influenza types also varied by transmission zone. In zones with elevated positivity, A(H1N1)pdm09 was predominant in Northern Europe, Eastern Africa, Western and South Eastern Asia, and Oceania. In Eastern Asia, A(H1N1)pdm09 and A(H3N2) were co-dominant. Influenza A and B were co-dominant in Central America and the Caribbean, Temperate South America, and Southern Asia. Influenza B was predominant in Tropical South America, Western Africa, and Middle Africa.\n\nThe update described SARS-CoV-2 positivity as stable and low across most reporting countries, while recording pockets above 10 percent in parts of South Western Europe and single countries in Central America and the Caribbean, Northern Europe, and Western Asia. One country in Northern Africa was above 30 percent. WHO also noted small increases in several named areas. These are surveillance signals for the reporting week, not evidence that every country or community followed the same trend.\n\nRSV positivity remained low globally in the report, but local readings exceeded 10 percent in a few countries in Central America and the Caribbean and in single countries in Tropical South America, Southern Asia, and Eastern Asia. Rates over 30 percent were reported in individual countries in Temperate South America and Southern Asia. Some areas reported elevated influenza and RSV at the same time, while the source cautions that different viruses may be sampled from different surveillance sources.\n\nWHO's severity section is a separate kind of national report. In northern temperate and subtropical areas, influenza-specific transmissibility was below the local seasonal threshold in 10 countries and classified as low in six; assessments based on syndromic data were below threshold in seven and low in one. The report says these assessments use each country's historical context and methods. They should not be ranked as though one country used an identical scale to another.\n\nThe report's methods explain why the maps smooth short-term movements. For influenza and SARS-CoV-2 trend analysis, WHO averaged positivity over three weeks and included countries that tested at least 10 specimens in at least two of those three weeks. Influenza subtype maps aggregate three weeks backward until a transmission zone reaches at least 100 tested samples. Those thresholds apply to specified analytical products, not to all figures in the bulletin.\n\nWHO says reporting completeness can change, countries can revise prior data, and grouped regions do not imply uniform transmission inside them. The summary was based on RespiMart data last updated on 9 November at 00:30 UTC, two days before publication. Newsverum reviewed the bulletin and its methods. The update supports a picture of uneven activity and changing test positivity, not a diagnosis, a forecast, or a direct comparison of infection risk between populations.","title":"WHO finds uneven respiratory virus activity in week 44 surveillance update","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=en","language":"en","url":"https://newsverum.com/en/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=es","language":"es","url":"https://newsverum.com/es/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=de","language":"de","url":"https://newsverum.com/de/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},{"api_url":"https://newsverum.com/api/v1/articles/who-global-respiratory-virus-surveillance-week44-2026-11-01?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"}],"url":"https://newsverum.com/en/news/who-global-respiratory-virus-surveillance-week44-2026-11-01"},"version":"1"}
